Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia

For acute leukemia (AL) with adverse prognostic factors, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the standard care option after the first complete remission. Meanwhile, as the success of haploidentical HSCT (haplo-HSCT), haploidentical donors (HIDs) become a reliable choice...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wenshuai, Wu, Yamei, Guan, Lixun, Cheng, Longcan, Hu, Yalei, Tan, Min, Yang, Yuhui, Ning, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773128/
https://www.ncbi.nlm.nih.gov/pubmed/36568184
http://dx.doi.org/10.3389/fonc.2022.986144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773128/
https://www.ncbi.nlm.nih.gov/pubmed/36568184
http://dx.doi.org/10.3389/fonc.2022.986144

Ejemplares similares